Company
Pfizer
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
1
510(k), De Novo and PMA
Device trials
25
As lead sponsor, any status
Adverse event reports
27
Received Nov 1, 2025 to Nov 19, 2026
Recall records
6
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements.
Listed
PFE
NYSE · PFIZER INC
Public float
$138.0B
Value of shares held by non-insiders on Jun 29, 2025
Revenue
$62.6B
Fiscal year ending Dec 31, 2025
Net income
$7.77B
Fiscal year ending Dec 31, 2025
R&D spending
$10.4B
Fiscal year ending Dec 31, 2025
Cash
$1.82B
As of Sep 27, 2026
Long-term debt
$60.0B
As of Sep 27, 2026
Shares outstanding
5699.9M
As of Oct 28, 2026
Capital raised as a public company
Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.
| Year | IPO | Stock sold | Long-term debt | Convertible debt |
|---|---|---|---|---|
| 2025 | – | – | $9.68B | – |
| 2023 | – | – | $30.8B | – |
| 2021 | – | – | $997M | – |
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
Latest FDA decisions
K181102 · Decided Sep 15, 2018 · 142 days after receipt
Device type: Stimulator, Nerve, Transcutaneous, Over-The-Counter (NUH) · Neurology & Neurosurgery
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT07542886 · 27 participants · Start Apr 22, 2026 · Primary completion Jun 25, 2026
Device: Marketed Genotropin Pen 12; New Genotropin Injector Pen · For: Healthy
Sites: Brussels, Belgium
NCT04823650 · 87 participants · Start Aug 23, 2021 · Primary completion Oct 28, 2024
Device: COHORT A: Actigraph; Panoramic Bracelet and GENEActiv · For: Child, Preschool; Child; Adolescent
Sites: Cambridge, Massachusetts
NCT01355653 · 45 participants · Start May 5, 2011 · Primary completion Jul 28, 2011
Device: thermal therapy; ThermaCare heatwrap · For: Back Pain
Sites: Loma Linda, California
22 more trials with a free account
Reports received
27
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
0.0% of reports
Injury reports
26
96% of reports
Death reports
1
3.7% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 0 | 0 | 0 |
| Jan 24 | 10 | 2 | 0 | 0 |
| Feb 24 | 6 | 0 | 0 | 0 |
| Mar 24 | 10 | 0 | 0 | 0 |
| Apr 24 | 5 | 1 | 0 | 0 |
| May 24 | 0 | 1 | 0 | 0 |
| Jun 24 | 8 | 17 | 4 | 0 |
| Jul 24 | 2 | 1 | 1 | 0 |
| Aug 24 | 2 | 8 | 1 | 0 |
| Sep 24 | 3 | 0 | 0 | 0 |
| Oct 24 | 15 | 1 | 0 | 0 |
| Nov 24 | 2 | 0 | 0 | 0 |
| Dec 24 | 1 | 2 | 0 | 0 |
| Jan 25 | 5 | 1 | 0 | 0 |
| Feb 25 | 8 | 1 | 0 | 0 |
| Mar 25 | 3 | 2 | 0 | 0 |
| Apr 25 | 1 | 1 | 0 | 0 |
| May 25 | 0 | 12 | 1 | 0 |
| Jun 25 | 0 | 2 | 0 | 0 |
| Jul 25 | 0 | 1 | 0 | 0 |
| Aug 25 | 0 | 1 | 0 | 0 |
| Sep 25 | 0 | 1 | 0 | 0 |
| Oct 25 | 1 | 1 | 0 | 0 |
| Nov 25 | 0 | 5 | 1 | 0 |
| Dec 25 | 0 | 1 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 8 | 0 | 0 |
| Mar 26 | 0 | 1 | 0 | 0 |
| Apr 26 | 0 | 1 | 0 | 0 |
| May 26 | 0 | 2 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 2 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 6 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- GELFOAM11
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0554-2019 · Started Oct 2, 2018
Reason given: The firm received complaints of the wrap coming apart and leaking granular material
Cause as FDA categorized it: Device Design · Device type: Pack, Hot Or Cold, Disposable (IMD)
Z-0555-2019 · Started Oct 2, 2018
Reason given: The firm received complaints of the wrap coming apart and leaking granular material
Cause as FDA categorized it: Device Design · Device type: Pack, Hot Or Cold, Disposable (IMD)
Z-0556-2019 · Started Oct 2, 2018
Reason given: The firm received complaints of the wrap coming apart and leaking granular material
Cause as FDA categorized it: Device Design · Device type: Pack, Hot Or Cold, Disposable (IMD)
3 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.